add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers
 

Mark I. Greene

Partner, Corporate

Mark I. Greene is the Head of Cravath’s Corporate Department and the Leader of the Firm’s International Practice.  His practice focuses on mergers and acquisitions, corporate governance and securities matters, including advising on cross-border and domestic transactions, private equity deals, complex restructuring transactions, proxy fights, takeover defense and hedge fund activism. According to clients and the market, Mr. Greene has a “mighty reputation in cross-border deals” and “outstanding and deep experience in M&A.” He “treats his clients as priority number one” and “takes time to probe and understand his clients’ objectives and is very practical in the legal advice he offers.” 

Mr. Greene has been named a “Dealmaker of the Year” by The American Lawyer, a “Cross-Border Dealmaker of the Year” by The Deal and a Mergers & Acquisitions Trailblazer by The National Law Journal.  He has been repeatedly recognized as a leading M&A practitioner by, among others, Chambers USA, Chambers Global, The Legal 500 US, The Legal 500 Latin America, IFLR1000 and Lawdragon. Mr. Greene has also been named one of the most valuable M&A lawyers in Germany by Welt am Sonntag

Mr. Greene counts among his diverse client base Unilever, Casa Cuervo, Novartis, Schneider Electric, Biogen, Mylan, RELX Group (formerly Reed Elsevier), Synthomer, Corteva, Axalta, Deutsche Börse, KION Group, FS Investments and Central Garden & Pet.

Mr. Greene advises on matters across a broad range of industries, including healthcare, consumer products, agriculture, industrials, energy, financial institutions, telecommunications, media and entertainment and blockchain and financial technology (FinTech). Notable transactions include representing:

  • Mylan N.V. in connection with its pending $50 billion combination with Upjohn, a division of Pfizer Inc.; its acquisition of global marketing rights to GA Depot through an investment in and partnership with Mapi Pharma; its $9.9 billion acquisition of Meda Aktiebolag (publ.); its acquisition of the non-sterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings, LLC for $950 million in cash at closing plus additional contingent payments of up to $50 million; its successful takeover defense against Teva Pharmaceutical Industries Ltd.’s $40 billion hostile bid; its proposal to acquire Perrigo Company plc in a transaction valued at approximately $35 billion; its acquisition of certain female healthcare businesses from Famy Care Limited for $750 million in cash plus additional contingent payments of up to $50 million; its $5.6 billion inversion acquisition of Abbott Laboratories’ non-U.S. developed markets specialty and branded generics business; its $550 million acquisition of Bioniche Pharma Holdings Limited; its €4.9 billion acquisition of the generic drug operations of Merck KGaA of Germany; and its acquisition of Synerx Pharma LLC;
  • Unilever in connection with numerous M&A transactions, including the $143 billion unsolicited offer from Kraft Heinz to acquire Unilever; its acquisition of OLLY Nutrition; its acquisition of Sundial Brands LLC; its $384 million acquisition of the TAZO brand from Starbucks Corporation; its acquisition of Seventh Generation, Inc.; its acquisition of Murad, Inc.; its acquisition of Dermalogica, Inc.; its acquisition of Talenti Gelato & Sorbetto; the sale of its Slim‑Fast brand to Kainos Capital; the $2.15 billion sale of its North America pasta sauces business under the Ragú and Bertolli brands to Mizkan Group; the $580 million sale of its Wish‑Bone and Western dressings brands to Pinnacle Foods Inc.; the $700 million sale of its global Skippy business to Hormel Foods; the $267 million sale of its North American frozen meals business to ConAgra Foods, Inc.; the $325 million sale of its Culver Specialty Brands division, which includes the Mrs. Dash, Molly McButter, Sugar Twin, Bakers and Static Guard brands in the United States and Canada, to B&G Foods, Inc.; its $3.7 billion acquisition of U.S.‑based Alberto‑Culver Company and the sale of its Alberto VO5 brand in the U.S. and Puerto Rico from the Alberto‑Culver portfolio and the Rave brand globally from the Unilever portfolio to private equity firm Brynwood Partners VI L.P.; and its $411.5 million acquisition of the TIGI professional hair product business and its supporting advanced education academies from the owners of the Toni & Guy Salons;
  • Synthomer plc in connection with its $824 million acquisition of OMNOVA;
  • Deutsche Börse AG in connection with its $850 million acquisition of Axioma, which was combined with Deutsche Börse’s index businesses valued at €2.6 billion, and its partnership with General Atlantic; its proposed $9.53 billion merger of equals with NYSE Euronext and the competing unsolicited proposal by NASDAQ OMX and Intercontinental Exchange, which was withdrawn;
  • Cholula in connection with its acquisition by L Catterton;
  • Novartis AG in connection with its $2.1 billion acquisition of Endocyte, its $470 million acquisition of Genoptix, Inc., and the $5.5 billion sale of its Gerber business to Nestlé S.A.;
  • RELX Group in connection with its acquisition of Emailage, its $375 million acquisition of ID Analytics, its acquisition of Aries Systems, its acquisition of Safe Banking Systems LLC, its £580 million acquisition of ThreatMetrix Inc., and LexisNexis Legal & Professional’s joint ventures with Knowable and LEAP Legal Software and LexisNexis’s acquisition of Health Market Science;
  • Jose Cuervo in connection with its $205 million acquisition of Pendleton Whisky brands;
  • FS Investments in connection with the transition of the management of its business development company (BDC) platform to investment advisory partnerships with EIG Global Energy Partners and KKR;
  • Biogen Inc. in connection with its $1.25 billion settlement and license agreement with Forward Pharma A/S;
  • KION Group AG in connection with its $2.1 billion acquisition of Dematic from funds managed by AEA Investors LP and Ontario Teachers’ Pension Plan, among others;
  • Casa Cuervo in connection with an asset swap with Diageo plc in which Casa Cuervo acquired The Old Bushmills Distillery Limited, including the Bushmills Irish Whiskey brand, and Diageo acquired full ownership and control of Don Julio Tequila plus cash in the amount of $408 million;
  • The transaction committee of the board of directors of Norwegian Cruise Line Holdings Ltd. in connection with the $3.025 billion acquisition of Prestige Cruises International, Inc. by Norwegian;
  • Central Garden & Pet Company in connection with a $1.1 billion unsolicited offer from Harbinger Group Inc.;
  • Integrys Energy Group, Inc. in connection with its $9.1 billion acquisition by Wisconsin Energy Corporation;
  • The special committee of the board of directors of CNH Global N.V. in connection with the merger of Fiat Industrial S.p.A. and CNH Global with and into CNH Industrial N.V.;
  • The Linde Group in connection with its $4.6 billion acquisition of Lincare Holdings Inc., a U.S.‑based homecare health company;
  • Schneider Electric S.A. in connection with its $1.5 billion acquisition of Pelco, Inc., and its $6.1 billion acquisition of American Power Conversion Corporation;
  • The Stanley Works in connection with its $4.5 billion acquisition of The Black & Decker Corporation to create Stanley Black & Decker, an $8.4 billion global industrial leader, in an all‑stock transaction;
  • Mangas Gaming, as U.S. counsel, in connection with its acquisition of 60% of the online gambling software business of GigaMedia Limited, including the Everest poker and casino brands;
  • NuVox, Inc. in connection with its $643 million acquisition by Windstream Corporation;
  • Perry Capital, LLC in connection with its equity investment in Universal American Financial Corp., the proceeds of which were used by Universal American in connection with its $630 million acquisition of MemberHealth, Inc. Mr. Greene also represented Perry Capital, LLC, as part of a consortium led by iStar Financial Inc., in connection with the $1.7 billion sale of TimberStar Southwest LLC to Mutual Financial Corp; and
  • Royal KPN N.V. through its wholly owned subsidiary KPN B.V. in connection with its $93.3 million acquisition of the 44% stake in iBasis Inc. not otherwise held by KPN.

Mr. Greene is a Fellow of the American College of Governance Counsel and serves on the Board of Advisors of the Institute for Law and Economics at the University of Pennsylvania. He also serves as President of the Board of Trustees of The Allen‑Stevenson School and is a Trustee of the Randall’s Island Park Alliance, both in New York City. 

Mr. Greene was born in Rockaway Beach, New York. He received a B.A. from Cornell University in 1989 and a J.D. from the University of Pennsylvania in 1993. Before joining Cravath, Mr. Greene served as a law clerk to Hon. Charles Legge of the U.S. District Court for the Northern District of California.

Mr. Greene joined Cravath in 1994 and was elected a partner in 2000.

Mr. Greene is admitted only in New York.

Contact
+1 (212) 474-1150
+1 (212) 474-3700